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TO THE EDITOR: We read with great interest the recently pub-
lished study by Coucha and colleagues (3) in American Journal
of Physiology-Heart and Circulatory Physiology on the asso-
ciation between protein nitration and myogenic tone impair-
ment in middle cerebral arteries (MCAs). This study provides
a mechanistic explanation for the previous observation that
myogenic tone impairment extends beyond the territory of the
occluded MCA (1, 5, 8) and indicates that peroxynitrite-
induced nitration is an important factor involved in myogenic
dysfunction after stroke (6). Advances in understanding com-
munication between the brain and periphery are relevant to
stroke research. The authors discuss the possibility that isch-
emia-reperfusion (I/R) injury may extend to vascular territories
outside the brain. Consistently, we have previously described
endothelial dysfunction in rat mesenteric resistance arteries
after transient MCA occlusion, a process likely linked to
excessive oxidative stress (7) (Fig. 1). Interestingly, the authors
unveil a previously unidentified physiological role of low
levels of peroxynitrite in MCA myogenic tone development,
acting through different mechanisms in both the ischemic and
the contralateral hemispheres (3). Certainly, further studies are
warranted to assess the nature of this coordinated and spatially
different action of peroxynitrite to maintain the homeostasis of
the brain’s microenvironment.
A time threshold of MCA occlusion has been described for
myogenic responses in rat MCAs (1, 2). Previous studies
suggest that once established, MCA myogenic impairment
extends into late stages (8). An important question that needs to
be addressed is whether it is possible and clinically relevant to
prevent/reverse myogenic impairment within a reasonable ther-
apeutic time window. In a previous study, ischemic rats devel-
oped smaller infarcts after treatment with an antioxidant ad-
ministered orally at 30 min after the onset of reperfusion,
though the I/R-induced myogenic impairment remained unal-
tered (4). In the study by Coucha et al. (3), several drugs are
intraperitoneally administered to elegantly describe the mech-
anisms involved on the aforementioned myogenic impairment
induced by I/R. We would greatly appreciate receiving a
comment from the authors on the therapeutic window of
opportunity for the treatments used in their investigation to
prevent/reverse myogenic impairment. It would also be inter-
esting to know the impact of these treatments on stroke
outcome (i.e., infarct volume and neurological deficits), since it
would provide valuable insights into the potential clinical
benefits of targeting MCA myogenic function after stroke.
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Fig. 1. Propagation of vascular dysfunction during
ischemia-reperfusion involves both brain hemispheres
and the periphery. MCA, middle cerebral artery; tMCAO,
transient middle cerebral artery occlusion; Ipsi, ipsilat-
eral; Contra, contralateral.
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